Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Alan J, Green"'
Autor:
Barry W. Wessels, Roger G. Dale, Marta Cremonesi, Ruby F. Meredith, Alan J. Green, Bertrand Brill, Wesley E. Bolch, George Sgouros, Stephen R. Thomas
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 25:597-599
Autor:
Philip Ross, Peter Amlot, Pei-San Chan, Christopher McNamara, Alan G. Ramsay, T. Andrew Lister, Alessandra Malaroda, Surinder K. Sharma, John R. Buscombe, Anmol Malhotra, Shokri Othman, Richard H. J. Begent, John Violet, Gairin Dancey, Roslyn J. Francis, Nicholas Woodward, Sweta Parker, Alan J. Green, Natalie Griffin
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 15(24)
Purpose: There is a need for new treatments for Hodgkin and T-cell lymphoma due to the development of drug resistance in a proportion of patients. This phase I study of radioimmunotherapy used CHT-25, a chimeric antibody to the α-chain of the interl
Autor:
Anwar R. Padhani, R. Barbara Pedley, Karen Owen, N. Jane Taylor, Andrew M. Gaya, Richard H. J. Begent, John Violet, Lisa K. Folkes, Kerry A. Chester, Pei-San Chan, Gordon J. S. Rustin, Shokri Othman, David Wellsted, Linda Poupard, Michael R.L. Stratford, Tim Meyer, Gairin Dancey, J. James Stirling, Alan J. Green, Alessandra Malaroda, Surinder K. Sharma, John R. Buscombe
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 15(13)
Purpose: In preclinical models, radioimmunotherapy with 131I-A5B7 anti–carcinoembryonic antigen (CEA) antibody (131I-A5B7) combined with the vascular disruptive agent combretastatin-A4-phosphate (CA4P) produced cures unlike either agent alone. We c
Autor:
Alan J Green
Publikováno v:
Studies in Ethics, Law, and Technology. 3
Autor:
Clare Cruickshank, John A. Hartley, Berend Tolner, Alan J. Green, Julie Wren, Geoff Boxer, Surinder K. Sharma, A Mayer, Jan Martin, Richard H. J. Begent, Roslyn J. Francis, Caroline J. Springer, Jimmy D. Bell, Kerry A. Chester
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 12(21)
Purpose: Antibody-directed enzyme prodrug therapy is a two-stage treatment whereby a tumor-targeted antibody-enzyme complex localizes in tumor for selective conversion of prodrug. The purpose of this study was to establish optimal variables for singl
Autor:
A Mayer, Kerry A. Chester, Barbara Pedley, Richard H. J. Begent, Surinder K. Sharma, John Violet, Geoff Boxer, Alan J. Green, Sylvia Nagl, Berend Tolner
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 25(1-2)
The 'magic bullet' concept predicted over a century ago that antibodies would be used to target cancer therapy. Since then initial problems that were related to specificity, purity and immungenicity of antibody-based reagents have slowly been overcom
Autor:
Jason L J, Dearling, Aiden A, Flynn, Julie, Sutcliffe-Goulden, Ingrid A, Petrie, Robert, Boden, Alan J, Green, Geoffrey M, Boxer, Richard H J, Begent, R Barbara, Pedley
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 45(1)
It has been shown in vitro that the cell uptake of (18)F-FDG, a tracer of glucose metabolism, increases under hypoxia. This is consistent with increased glycolytic metabolism. We have previously shown that in ischemic heart ex vivo the rates of uptak
Autor:
AA Flynn, Geoffrey M. Boxer, Alan J. Green, Robert Boden, Richard H. J. Begent, R. Barbara Pedley
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 16(5)
The biological effect of radioimmunotherapy (RIT) is most commonly assessed in terms of the absorbed radiation dose. In tumor, conventional dosimetry methods assume a uniform radionuclide and calculate a mean dose throughout the tumor. However, the v
Autor:
Geoffrey M Boxer, Richard H. J. Begent, Aiden A Flynn, R. Barbara Pedley, Alan J. Green, Joanne L. Casey
Publikováno v:
International journal of radiation oncology, biology, physics. 43(1)
Purpose: Radioimmunotherapy of cancer employs an antitumour antibody to carry a radionuclide selectively to deposits of cancer. Conventional dose estimates, based on the Medical Internal Radiation Dose (MIRD) formulation, assume uniform distribution
Autor:
Alan J. Green, Kenneth F. Koral, Ronald J. Jaszczak, George T.Y. Chen, Peter K. Leichner, John C. Roeske
Publikováno v:
Medical physics. 20(2 Pt 2)
Planar and tomographic imaging techniques and methods of treatment planning in clinical radioimmunotherapy are reviewed. In clinical trials, the data needed for dosimetry and treatment planning are, in most cases, obtained from noninvasive imaging pr